Zimmer Biomet Holdings Inc (ZBH) Stock Forecast & Predictions

Zimmer Biomet Holdings Inc ZBH: $164.47

345 E Main St, Warsaw, Indiana, US. | Sector: Manufacturing | Exchange: NEW YORK STOCK EXCHANGE, INC. | Web: www.zimmerbiomet.com

  • Market Cap$34.69B
  • Change (52 Weeks)33.01%
  • Low (52 Weeks)$111.22
  • Zimmer Biomet Holdings Inc (ZBH) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 25.00% are on Buy, 25.00% on Sell, and 50.00% Neutral.

    According to the market data, Zimmer Biomet Holdings Inc (ZBH) stock price is $164.47 and the 52 weeks low is $111.22, which means the Zimmer Biomet Holdings Inc stock price is up 33.01% in the last 12 months.

    Zimmer Biomet Holdings Inc (ZBH) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant changes take place in the market performance or news.

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 25.00% are indicating that ZBH Stock price might rise further, 25.00% indicating that ZBH Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall ZBH stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Zimmer Biomet Holdings Inc (ZBH) Stock Forecast By Analysts


    Moderate Buy
    Analysts Recommendations for Zimmer Biomet Holdings Inc (ZBH) is based on 33 Institutional Analyst Ratings where 36.36% are on Strong Buy, 42.42% on Moderate Buy, 18.18% remains on Hold, 0.00% are on Moderate Sell and 3.03% are on Strong Sell.

    Out of 33 Institutional Analysts, majority recommended ZBH stock as Moderate Buy. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Zimmer Biomet Holdings Inc.

    Zimmer Biomet Holdings Inc (ZBH) Stock Price Prediction By Analysts


    HighLowAverage
    $220.50$135.34$195.41
    $195.4118.81% Upside
    Updated: 2021-06-18 00:00:00

    The Average Price target for ZBH set by the institutional analysts is $195.41 where High Estimate is $220.50, Median $198.9 and Low $135.34.

    The average price target for ZBH by Institutional Analysts is $195.41, which is 18.81% Upside from the current price. So according to the Institutional Analysts, ZBH Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Zimmer Biomet Holdings Inc (ZBH) Stock Forecast Based on Investor Sentiment


    Very Positive

    Based on 434,839 investor portfolio.

    Our algorithm has analysed 434,839 investor portfolio with ZBH stock holdings and found that 99.50% of them are bullish. Which means the Investor Sentiment is mostly Very Positive.

    This shows most investors are very optimistic about ZBH and holding their positions hoping for a further rise in the stock price and more profit.

    Zimmer Biomet Holdings Inc (ZBH) Stock Forecast Based on News Sentiment


    Neutral
    Based on 2 articles published Last Week, where 50.00% are Bullish and 50.00% are Bearish.

    According to the news articles published last week, journalists and bloggers had a mixed sentiment of ZBH consisting of positive and negative, it shows that Zimmer Biomet Holdings Inc had a neutral news coverage.

    Neutral news coverage usually doesn't affect short-term price of a stock, so ZBH stock price most likey won't have any reaction to last weeks news coverage.

    Zimmer Biomet Holdings Inc (ZBH) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    BarclaysOverweightInitiated
    JMP SecuritiesMarket OutperformMaintained
    SVB LeerinkOutperformMaintained
    Raymond JamesStrong BuyMaintained
    Canaccord GenuityBuyMaintained
    Northland Capital MarketsOutperformUpgraded
    Wells FargoOverweightMaintained
    SVB LeerinkOutperformMaintained
    Raymond JamesStrong BuyMaintained
    Morgan StanleyOverweightMaintained
    Deutsche BankHoldMaintained
    NeedhamStrong BuyMaintained
    JMP SecuritiesMarket OutperformMaintained
    BTIGBuyMaintained
    Evercore ISI GroupOutperformUpgraded
    Morgan StanleyOverweightMaintained
    SVB LeerinkOutperformMaintained
    SVB LeerinkOutperformMaintained
    Credit SuisseUnderperformMaintained
    Northland Capital MarketsMarket PerformInitiated
    Raymond JamesStrong BuyMaintained
    SVB LeerinkOutperformMaintained
    Wolfe ResearchOutperformInitiated
    SVB LeerinkOutperformMaintained
    Raymond JamesStrong BuyMaintained
    NeedhamStrong BuyMaintained
    Morgan StanleyOverweightMaintained
    SVB LeerinkOutperformMaintained
    JMP SecuritiesMarket OutperformMaintained
    Wells FargoOverweightMaintained
    UBSBuyMaintained
    SVB LeerinkOutperformMaintained
    SunTrust Robinson HumphreyBuyMaintained
    StifelBuyMaintained
    Raymond JamesStrong BuyMaintained
    OppenheimerOutperformMaintained
    Deutsche BankHoldMaintained
    CitigroupBuyMaintained
    Canaccord GenuityBuyMaintained
    NeedhamStrong BuyMaintained
    GuggenheimNeutralDowngraded
    Raymond JamesStrong BuyMaintained
    Evercore ISI GroupIn-LineDowngraded
    SVB LeerinkOutperformMaintained
    SunTrust Robinson HumphreyBuyMaintained
    NeedhamStrong BuyMaintained
    BTIGBuyMaintained
    Morgan StanleyOverweightMaintained
    CitigroupBuyMaintained
    StifelBuyMaintained
    Credit SuisseUnderperformMaintained
    CitigroupBuyInitiated
    Goldman SachsBuyInitiated
    Raymond JamesStrong BuyMaintained
    Morgan StanleyOverweightMaintained
    Deutsche BankHoldMaintained
    Credit SuisseUnderperformMaintained
    BairdOutperformMaintained
    NeedhamStrong BuyReiterated
    Wells FargoOverweightMaintained
    SunTrust Robinson HumphreyBuyInitiated
    Piper SandlerOverweightUpgraded
    NeedhamStrong BuyMaintained
    Morgan StanleyOverweightMaintained
    Raymond JamesStrong BuyUpgraded
    UBSBuyMaintained
    RBC CapitalOutperformMaintained
    Raymond JamesOutperformMaintained
    BTIGBuyUpgraded
    Canaccord GenuityBuyUpgraded
    Wells FargoOutperformMaintained
    ArgusBuyUpgraded
    CitiBuyMaintained
    BarclaysEqual-WeightUpgraded
    Wells FargoOutperformMaintained
    Raymond JamesOutperformMaintained
    Morgan StanleyOverweightMaintained
    BairdOutperformUpgraded
    BernsteinMarket PerformUpgraded
    NeedhamStrong BuyUpgraded
    BarclaysUnderweightMaintained
    Evercore ISI GroupOutperformUpgraded
    Morgan StanleyOverweightMaintained
    Deutsche BankHoldInitiated
    Morgan StanleyOverweightMaintained
    CitigroupBuyUpgraded
    JP MorganNeutralDowngraded
    Credit SuisseUnderperformInitiated
    UBSBuyInitiated
    JefferiesBuyMaintained
    CitigroupNeutralMaintained
    BarclaysUnderweightMaintained
    BarclaysUnderweightInitiated
    Morgan StanleyOverweightMaintained
    BTIG ResearchNeutralInitiated
    NeedhamBuyDowngraded
    CitigroupNeutralMaintained
    Raymond JamesOutperformMaintained
    JMP SecuritiesMarket OutperformMaintained
    Cantor FitzgeraldOverweightMaintained
    Canaccord GenuityHoldMaintained
    BairdNeutralMaintained
    BernsteinUnderperformInitiated
    ArgusHoldDowngraded
    Morgan StanleyOverweightMaintained
    JMP SecuritiesMarket OutperformMaintained
    Evercore ISI GroupIn-LineInitiated
    BairdNeutralDowngraded
    Raymond JamesOutperformInitiated
    CitigroupNeutralMaintained
    CitigroupNeutralMaintained
    Morgan StanleyOverweightMaintained
    Stifel NicolausBuyUpgraded
    Leerink SwannOutperformMaintained
    Goldman SachsNeutralUpgraded
    Deutsche BankBuyUpgraded
    Edward JonesBuyUpgraded
    PiperJaffrayNeutralDowngraded
    Morgan StanleyOverweightMaintained
    BMO CapitalOutperformMaintained
    Gabelli & Co.BuyInitiated
    Leerink SwannOutperformMaintained
    Canaccord GenuityHoldDowngraded
    BMO CapitalOutperformMaintained
    Morgan StanleyOverweightMaintained
    GuggenheimBuyUpgraded
    Cantor FitzgeraldNeutralInitiated
    Goldman SachsSellInitiated
    Wells FargoMarket PerformDowngraded
    UBSSellDowngraded
    Northcoast ResearchNeutralDowngraded
    NeedhamStrong BuyUpgraded
    BarclaysOverweightMaintained
    SunTrust Robinson HumphreyBuyInitiated
    UBSNeutralMaintained
    JP MorganOverweightMaintained
    JMP SecuritiesMarket OutperformMaintained
    JefferiesBuyMaintained
    CitigroupSellMaintained
    BarclaysOverweightMaintained
    GuggenheimNeutralInitiated
    ArgusBuyUpgraded
    Leerink SwannOutperformMaintained
    NomuraBuyInitiated
    ArgusHoldDowngraded
    Credit SuisseOutperformMaintained
    JMP SecuritiesMarket OutperformMaintained
    Northland SecuritiesMarket PerformDowngraded
    CitigroupSellInitiated
    Sterne Agee CRTBuyInitiated
    Goldman SachsNeutralInitiated

    Zimmer Biomet Holdings Inc (ZBH) Stock Earning Per Share (EPS) Forecast / Estimate


    $1.954
    The average consensus EPS for ZBH is $1.954 with a high estimate of $2.226 and Low of $1.715 for the period 2021-09-30 and based on 28 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $1.71$1.54388599999999992021-03-31


    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $$1.88244812021-06-30
    $1.71$1.54388599999999992021-03-31
    $2.11$2.0776712020-12-31
    $1.81$1.0771652020-09-30
    $0.05$-0.7381082020-06-30
    $1.7$1.3963252020-03-31
    $2.3$2.289672019-12-31
    $1.77$1.7698232019-09-30
    $1.93$1.9328372019-06-30
    $1.87$1.8821352019-03-31
    $2.18$2.1943262018-12-31
    $1.63$1.6209492018-09-30
    $1.92$1.8983962018-06-30
    $1.91$1.9045572018-03-31
    $2.1$2.118982017-12-31
    $1.72$1.7578042017-09-30
    $2.08$2.1171622017-06-30
    $2.13$2.1306962017-03-31
    $2.14$2.1324132016-12-31
    $1.79$1.8092132016-09-30
    $2.02$1.9863672016-06-30
    $2$1.9500072016-03-31
    $2.09$2.0610062015-12-31
    $1.64$1.5760042015-09-30
    $1.59$1.56307600000000012015-06-30
    $1.58$1.5295442015-03-31
    $1.71$1.72194900000000022014-12-31
    $1.35$1.3153232014-09-30
    $1.49$1.5032842014-06-30
    $1.5$1.481672014-03-31
    $1.66$1.6333722013-12-31
    $1.25$1.255432013-09-30
    $1.43$1.45692499999999982013-06-30
    $1.41$1.4173332013-03-31
    $1.51$1.50793000000000022012-12-31
    $1.15$1.13715899999999982012-09-30
    $1.34$1.3296652012-06-30
    $1.3$1.3145152012-03-31
    $1.36$1.3526932011-12-31
    $1.04$1.04032011-09-30

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).